Below are the most recent publications written about "Organs at Risk" by people in Profiles.
-
Guardiola C, De Marzi L, Prezado Y. Verification of a Monte Carlo dose calculation engine in proton minibeam radiotherapy in a passive scattering beamline for preclinical trials. Br J Radiol. 2020 Mar; 93(1107):20190578.
-
McNamara A, Willers H, Paganetti H. Modelling variable proton relative biological effectiveness for treatment planning. Br J Radiol. 2020 Mar; 93(1107):20190334.
-
Lin Y, Clasie B, Liu T, McDonald M, Langen KM, Gao H. Minimum-MU and sparse-energy-layer (MMSEL) constrained inverse optimization method for efficiently deliverable PBS plans. Phys Med Biol. 2019 10 10; 64(20):205001.
-
Otter SJ, Stewart AJ, Devlin PM. Modern Brachytherapy. Hematol Oncol Clin North Am. 2019 12; 33(6):1011-1025.
-
Marteinsdottir M, Paganetti H. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer. Phys Med Biol. 2019 06 05; 64(11):115027.
-
Hamming-Vrieze O, Depauw N, Craft DL, Chan AW, Rasch CRN, Verheij M, Sonke JJ, Kooy HM. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients. Phys Med Biol. 2019 04 23; 64(9):095001.
-
Gorissen BL. Comment on 'Linear energy transfer incorporated intensity modulated proton therapy optimization'. Phys Med Biol. 2019 02 27; 64(5):058001.
-
Choi HJ, Park H, Shin WG, Kim JI, Min CH. Development of a Geant4-based independent patient dose validation system with an elaborate multileaf collimator simulation model. J Appl Clin Med Phys. 2019 Feb; 20(2):94-106.
-
Ho AY, Ballangrud A, Li G, Gupta GP, McCormick B, Gewanter R, Gelblum D, Zinovoy M, Mueller B, Mychalczak B, Dutta P, Borofsky K, Parhar P, Reyngold M, Braunstein LZ, Chawla M, Krause K, Freeman N, Siu CT, Cost Z, Arnold BB, Zhang Z, Powell SN. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1100-1108.
-
Abouegylah M, Braunstein LZ, Alm El-Din MA, Niemierko A, Salama L, Elebrashi M, Edgington SK, Remillard K, Napolitano B, Naoum GE, Sayegh HE, Gillespie T, Farouk M, Ismail AA, Taghian AG. Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy. Breast Cancer Res Treat. 2019 Feb; 174(1):179-185.